Patent · US Active

Crystalline forms of dimethoxy docetaxel and methods for preparing the same

US10160739B2 · kind B2 · utility

0Cited by

6References

1Claims

0Family size

Assignee

AVENTIS PHARMA S.A. · FR

Inventors

Pascal Billot · Paris, FR
Marielle DUFRAIGNE · Brunoy, FR
Hagit Elmaleh · Paris, FR
Fabrice MANGIN · Paris, FR
Patricia RORTAIS · Paris, FR
Lionel ZASKE · Cournon-d'Auvergne, FR
Alexandre Giuliani · Villecresnes, FR

Key dates

Filing date	Jul 11, 2017
Grant date	Dec 25, 2018
Priority date	—
Expiry date	Jul 11, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to anhydrides, solvates and ethanol hetero-solvates and hydrates of dimethoxy docetaxel or (2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenyl-propionate of 4-acetoxy-2α-benzoyloxy-5β,20-epoxy-1-hydroxy-7β, 10β-dimethoxy-9-oxo-tax-11-ene-13α-yle, and to the preparation thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.